Publication | Open Access
Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor.
234
Citations
31
References
1988
Year
Monocyte-derived Neutrophil-activating FactorInnate Immune SystemImmunologyEscherichia ColiInnate ImmunityDrug ResistanceInflammationAntimicrobial ResistanceHealth SciencesGranulocyteVirulence Factor72-Amino Acid NafBiological EquivalenceMolecular MicrobiologyClinical MicrobiologyPhagocytePathogenesisMicrobiologyMedicineHuman Neutrophils
The neutrophil-activating factor (NAF) purified from the conditioned medium of lipopolysaccharide-stimulated human monocytes was sequenced and found to consist of 72 amino acids: SAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRA ENS. Purified preparations of natural NAF contained, in addition to this main form, minor amounts of three amino-terminal variants with 77 (+AVLPR), 70, and 69 residues. A gene coding for the 72-amino acid NAF was synthesized, cloned, and expressed in Escherichia coli. Western (immunologic) blot analysis of crude bacterial extracts, with an antiserum raised against natural NAF, revealed a single band that comigrated with natural NAF. Recombinant NAF purified to homogeneity had identical amino- and carboxyl-terminal sequences to the 72-amino acid natural NAF. Recombinant NAF was tested on human neutrophils and had the same activity and potency as natural NAF in inducing chemotaxis, rapidly increasing cytosolic free Ca2+, activating the respiratory burst, and releasing specific and azurophilic granular contents.
| Year | Citations | |
|---|---|---|
Page 1
Page 1